MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Allosteric regulation is crucial for protein function.
• Morpheeins are homo-oligomeric proteins exhibiting unique allosteric mechanisms.
• Understanding morpheein dynamics is key for novel drug discovery.

Purpose of the Study:

• To introduce the morpheein model as a novel framework for allosteric regulation.
• To explore the application of the morpheein model in small molecule drug discovery.
• To discuss potential drug targets amenable to the morpheein model.

Main Methods:

• The study focuses on the conceptual framework of the morpheein model.
• It analyzes the dissociation-alteration-reassociation mechanism of morpheeins.
• Case studies, including porphobilinogen synthase, are used for illustration.

Main Results:

• The morpheein model provides a basis for understanding allostery, conformational diseases, and drug discovery.
• Porphobilinogen synthase serves as a prototype, linking porphyria and antimicrobial discovery.
• Potential applications extend to targets like HIV integrase, TNFα, β-tryptase, and p53.

Conclusions:

• The morpheein model offers a versatile platform for identifying allosteric modulators.
• This approach has implications for treating conformational diseases and developing personalized medicine.
• Further research into morpheein-based drug discovery holds significant therapeutic promise.